Drugmaker Wockhardt posted a consolidated loss of \u20b9102 crore for the three months ended December 31, 2022. The company posted a profit of \u20b92 crore in the same period last year. It clocked revenues of \u20b9699 crore in the quarter under review, as compared to \u20b9854 crore in the corresponding quarter of the previous year. Wockhardt said, the corresponding quarter of the previous year included revenue and profitability from its vaccines business in the UK.<\/p>\n\n\n\n
The company\u2019s UK business stood at \u20b9223 crore in Q3FY23, contributing about 32 per cent of its global revenue. Its India business locked revenues of \u20b9175 crore, compared to \u20b9158 crore in Q3FY22. India contributed about 25 per cent of the global revenue. Its emerging markets business stood at Rs 148 crore in Q3FY23, compared to Rs 117 crore in Q2FY23, the company said. The region contributed about 21 percent of its global revenue.<\/p>\n\n\n\n
Wockhardt\u2019s US business stood at \u20b991 crore in Q3FY23, a region that accounted for 13 percent of the global revenue. The company said its management had initiated steps to restructure its USA business by closing down its manufacturing facility in Illinois, and undertake its business in the region through contract manufacturing the products sold by it in US\/North America by engaging USFDA approved manufacturing partners.<\/p>\n\n\n\n
Accordingly, the Group provided for \u20b9123 crore with regard to this property, plant and equipment, \u20b916 crore for inventory and other expenses of \u20b99 crore (including Rs three crore during the current quarter) pursuant to this restructuring, it explained. Wockhardt has also accounted for a contract asset of \u20b950 crore pursuant to a contract manufacturing agreement, it said. \u201cThe customer is yet to fulfill its contractual obligations and commitments. Though, the company is pursuing various options and taking necessary actions related to this matter, given the uncertainty, (the) company has provided for this Contract asset,\u201d it added.<\/p>\n","protected":false},"excerpt":{"rendered":"
Drugmaker Wockhardt posted a consolidated loss of \u20b9102 crore for the three months ended December 31, 2022. The company posted a profit of \u20b92 crore in the same period last year. It clocked revenues of \u20b9699 crore in the quarter under review, as compared to \u20b9854 crore in the corresponding quarter of the previous year. […]<\/p>\n","protected":false},"author":1863,"featured_media":27118,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392,5747],"tags":[10304,10306,10439],"class_list":["post-142390","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-earnings","category-healthcare-stocks","tag-api","tag-generic-drug","tag-vaccine"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":140755,"url":"https:\/\/alphastreet.com\/india\/zomatos-q3fy23-net-loss-widens-to-rs-347-crore\/","url_meta":{"origin":142390,"position":0},"title":"Zomato’s Q3FY23 net loss widens to Rs 347 crore","author":"Chirag Gupta","date":"February 9, 2023","format":false,"excerpt":"Zomato's consolidated net loss for Q3FY23 widened to Rs 347 crore against Rs 63 crore registered in the same quarter last year, the online food delivery platform announced on February 9. For Q2FY23, the net loss stood at Rs 251 crore. The Gurugram-headquartered company's revenue from operations zoomed 75 percent\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/bfc6db61-50cb-4cc5-b9d0-45805fc19045.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/bfc6db61-50cb-4cc5-b9d0-45805fc19045.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/bfc6db61-50cb-4cc5-b9d0-45805fc19045.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/bfc6db61-50cb-4cc5-b9d0-45805fc19045.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/bfc6db61-50cb-4cc5-b9d0-45805fc19045.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/bfc6db61-50cb-4cc5-b9d0-45805fc19045.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":141356,"url":"https:\/\/alphastreet.com\/india\/zomato-reported-a-net-loss-of-inr-347-crores-in-q3fy23\/","url_meta":{"origin":142390,"position":1},"title":"Zomato reported a net loss of INR 347 Crores in Q3FY23","author":"Chirag Gupta","date":"February 13, 2023","format":false,"excerpt":"Zomato\u2019s consolidated net loss for Q3FY23 widened to Rs 347 crore against Rs 63 crore registered in the same quarter last year, the online food delivery platform announced on February 9. For Q2FY23, the net loss stood at Rs 251 crore. The Gurugram-headquartered company\u2019s revenue from operations zoomed 75 percent\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"earnings preview","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":140936,"url":"https:\/\/alphastreet.com\/india\/zydus-lifescience-net-profit-soars-by-23-in-q3fy23\/","url_meta":{"origin":142390,"position":2},"title":"Zydus lifescience net profit soars by 23% in Q3FY23","author":"Chirag Gupta","date":"February 10, 2023","format":false,"excerpt":"Zydus Lifesciences Ltd reported a 23 per cent rise in consolidated net profit at INR 631 crore for the third quarter ended December 31, 2022. The company had posted a consolidated net profit of INR 511 crore in the same period last fiscal, Zydus Lifesciences Ltd said in a regulatory\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"earnings preview","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":140022,"url":"https:\/\/alphastreet.com\/india\/zydus-lifesciences-q3fy23-net-profit-rises-by-23-revenue-soars-20\/","url_meta":{"origin":142390,"position":3},"title":"Zydus Lifesciences Q3FY23 net profit rises by 23%; Revenue soars 20%","author":"Chirag Gupta","date":"February 3, 2023","format":false,"excerpt":"Zydus Lifesciences Ltd reported a 23 per cent rise in consolidated net profit at INR 631 crore for the third quarter ended December 31, 2022. The company had posted a consolidated net profit of INR 511 crore in the same period last fiscal, Zydus Lifesciences Ltd said in a regulatory\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/33edfd75-01f5-4dce-afe1-d8884b831eec.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/33edfd75-01f5-4dce-afe1-d8884b831eec.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/33edfd75-01f5-4dce-afe1-d8884b831eec.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/33edfd75-01f5-4dce-afe1-d8884b831eec.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/33edfd75-01f5-4dce-afe1-d8884b831eec.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/33edfd75-01f5-4dce-afe1-d8884b831eec.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":142658,"url":"https:\/\/alphastreet.com\/india\/vedant-fashions-q3fy23-net-profit-rises-by-18-per-cent\/","url_meta":{"origin":142390,"position":4},"title":"Vedant Fashions Q3FY23 net profit rises by 18 per cent","author":"Chirag Gupta","date":"February 23, 2023","format":false,"excerpt":"Vedant Fashions, which owns the ethnic wear brand Manyavar, has recorded a 17.6 percent rise in consolidated net profit at Rs 150.35 crore in the third quarter (Q3) ended December 31 of the current fiscal 2022-23 as against the profit of Rs 127.80 crore in the same period of the\u2026","rel":"","context":"In "Earnings"","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"earnings preview","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2019\/04\/Earnings-preview-1.jpg?resize=1050%2C600&ssl=1 3x"},"classes":[]},{"id":143067,"url":"https:\/\/alphastreet.com\/india\/earnings-kalyan-jewellers-india-limited-nsekalyankjil-q3fy23-results-out-total-income-rise-13-yoy\/","url_meta":{"origin":142390,"position":5},"title":"Earnings | Kalyan Jewellers India Limited (NSE:KALYANKJIL): Q3FY23 Results Out; Total Income rise 13% YoY","author":"Divyansh_Kasana","date":"March 1, 2023","format":false,"excerpt":"Kalyan Jewellers India Limited (NSE:KALYANKJIL) is a leading jewellery retail chain in India, founded in 1993. The company operates over 150 showrooms across India, the Middle East, and Southeast Asia, offering a wide range of gold, diamond, and other precious stone jewellery. Kalyan Jewellers is known for its exquisite designs\u2026","rel":"","context":"In "LATEST"","block_context":{"text":"LATEST","link":"https:\/\/alphastreet.com\/india\/category\/latest\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=142390"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/142390\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/27118"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=142390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=142390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=142390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}